In India, Cultured Cartilage Cells Re-Injected Into Young Patients to Repair Cartilage

Cultured Cells Injected to Repair Knee (Biloine Young @ OTW) Faced with a patient with a severely disabling injury on her left knee, doctors at JPN Hospital in New Delhi successfully performed their first “third generation autologous chondrocyte implantation.” According to the report in The Hindu, doctors used the patient’s own cultured cells to repair damage to [...]

Zimmer and ISTO Provide and Update on the Engineered Juvenile Cartilage Studies

  Zimmer, ISTO Advance Engineered Juvenile Cartilage Studies (Lauren Uzdienski @ HealthPointCapital) Zimmer and ISTO Technologies provided an update yesterday on their research program on engineered juvenile cartilage for the repair of damaged knees. The company plans to enroll up to 225 patients at 25 sites in a new phase III study, which will compare the use of the [...]

Unique Israeli Company CartiHeal Gets CE for Cartilage Defect Repair

     Unique Israeli Company CartiHeal Gets CE Mark (Biloine Young @ OTW) An Israeli company has received CE Mark certification for the EU for a cartilage defect repair product, based solely on a preclinical trial. The company is CartiHeal Ltd and the product is Agili-C. Nir Altschuler, a biomedical engineer who founded the company in [...]

CartiHeal Raises $5M for Agili-CTM, a Single-Stage Arthroscopic Cartilage Regeneration

  CartiHeal Raises $5 Million in Financing to Support Agili-CTM For Single Stage Arthroscopic Cartilage Regeneration (press release) CartiHeal  Ltd, a privately held medical device company, focused on developing and bringing to market a proprietary, off-the-shelf, and cell-free cartilage regeneration technology, announced that it raised $5 million in venture funding from two US-Israeli venture capital firms, [...]

British Surgeons Are Using the TiGenix Technology to Re-Grow Knee Cartilage

        Brits Re-Grow Knee Cartilage (written by Biloine Young @ OTW) A 50-year-old British mother is pain free for the first time in six years, she says, after undergoing a revolutionary new treatment to have her damaged knee cartilage re-grown. This is the first time the re-growth treatment was used outside of clinical [...]

Researchers Are Competing to Coax Chondrocytes Into Creating Cartilage

New Cartilage for Knee Pain (written by Biloine Young @ OTW) In a process not unlike the race to map the human genome, researchers are competing to coax chondrocytes into creating cartilage—the connective tissue in joints that helps to distribute weight and allows bones to slide past one another without causing pain. Age brings damages to [...]

Orthopedic Surgeons in Austin Are Injecting Bone Marrow Stem Cells Into Knee Joints to Reduce Inflammation

  Texas Docs Injecting Stem Cells  (Bilione Young @ OTW) Dr. Robert Johnson, an orthopedic surgeon in Austin, Texas, took stem cells from the bone marrow of the hip of a 59-year-old man and injected it back into the patient’s knee joints. The result? Johnson said the stem cells reduced inflammation and pain and then became [...]

2 Autologous Cartilage Regeneration Companies Merge – Biotech Firms Histogenics and ProChon

Biotech Firms Histogenics and ProChon Merge (OTW) Histogenics Acquires ProChon Biotech in an All-Stock Transaction (HealthPointCapital) Histogenic acquired ProChon Biotech in an all-stock exchange this week, with the companies declining to announce a dollar amount for the transaction. Both companies are developing autologous cartilage regeneration products. Histogenics has begun phase III studies of its NeoCart product [...]

Surgeons Prefer 3-Cycle HA Viscosupplement Injections Over the New 1-Cycle Injections

  Hyaluronic Acid Products from Genzyme, Sanofi-Aventis Preferred Among Orthopedic Surgeons, According to Survey (press release) According to a comprehensive global survey of orthopedic surgeons conducted by iData Research (www.idataresearch.net), the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation (HA) treatment in the U.S., Europe and Latin Ameica, but are [...]

Sanofi to Acquire Genzyme for 4.7X Sales Multiple

Sanofi-Aventis to Acquire Genzyme (LAUREN UZDIENSKI @ HealthPointCapital) After a long and very public negotiation, Genzyme has agreed to be acquired by Sanofi-Aventis for $74 per share, with the total deal valued at around $20.1 billion. The transaction represents a 48% increase over the close on July 2, before rumors began to circulate that Genzyme was an [...]

Arthrex to Distribute Kensey Nash’S Knee Cartilage Repair Scaffold in Europe

Kensey Nash and Arthrex Announce European Distribution Agreement for the Cartilage Repair Device

Chinese Government Approves Pricing & Reimbursement for NeoStem’S Arthroscopic Orthopedic Autologous Adult Stem Cell Based Treatment

Local Chinese Government Authorities Approve Pricing and Reimbursement for NeoStem’s Licensed Adult Stem Cell Treatments for Orthopedic Applications in China (Press Release) NeoStem holds an exclusive royalty-bearing, perpetual and irrevocable license to use the Regenerative Sciences, Inc. stem cell-based orthopedic technology in Asia, and is in the early stages of implementing operations designed to offer these [...]

Smith and Nephew and Nanotope Agree to Collaborate on Development of Cartilage Regeneration Technology

Arrowhead Portfolio Company, Nanotope, Inc. Enters Agreement with Smith & Nephew for the License and Development of Cartilage Regeneration Technology (Press Release) Nanotope website - Nanotope is developing a suite of products, each customized to regenerate specific tissues; including neuronal, vascular, bone, myocardial, and cartilage. The products are injectable compounds that work with surviving cells in [...]

VIDEO: Dr. Kevin Stone Talks About the Bio-Future of Joint Replacement

VIDEO:   Dr. Kevin Stone talks about the bio-future of joint  replacement (6 min. TED talk) Trends to watch in Orthopedic Surgery

UK to Carry Out a Stem Cell Arthritis Trial by Reimplanting Mesenchymal Cells and Chondrocytes

Stem cell trial for osteoarthritis launched (InPharm)

BioSyntech Closes Asset Sale to Indian Investor, Piramal Healthcare Ltd(PIRA.BO), for $3.9M

Piramal Health to buy Biosy  ntech for C$3.9 mln (Reuters India)

Connecticut Researchers Are Turning Embryonic Stem Cells Into Chondrocytes

Connecticut Researchers Turn Stem Cells into Chondrocytes (HealthPointCapital)

ISTO’s Breakthrough in Cartilage Regeneration —> Harvested Cartilage Cells From Deceased Juveniles

ISTO’s Cartilage Regeneration Breakthrough (Orthopedics This Week) The paper, “The Potential of Human Allogeneic Juvenile Chondrocytes for Restoration of Articular Cartilage,” is scheduled to appear in the July 2010 edition of The American Journal of Sports Medicine.

Will the FDA Take Back ReGen Biologics 510(k) Clearance?

  The entire orthopedic industry is watching this unprecedented FDA relook?   Does the FDA have the authority to take back a 510(k)?   If so, on what basis?   What impact will this have on your 510(k) cleared products?   Read recent publications below… FDA Agenda and Meeting Materials   FDA.gov FDA Wrestles With Undoing Decision  WSJ (Mar 22) [...]

Carticept Medical Gets $20M in Series B Financing

Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that it has completed a $20 million Series B financing round. New investor SonoSite, Inc. joined existing investors Domain Associates and New Enterprise Associates. The financing will provide funding for the expected commercial launch of the Company’s [...]

keep looking »

May 18, 2012

  • Newsletter Signup

  • Orthopedic Recruiting

    Now Hiring: Product Development Engineer - Memphis, TN

     

  • Editor – Tiger Buford

     


  •  

  • most popular this week

  • Monthly Articles

  • RSS Orthopedics This Week

  • RSS MedPageToday

  • Support OrthoStreams

  • Book of the Month